Abstract
Treatment of subclinical hypothyroidism may be recommended in patients with atrial fibrilation, in patients aged>60 years, and in the patients with documented osteopenia/osteoporosis, mainly if the TSH is<0,1 mIU/l. There is no evidence for benefit of treatment in patients with TSH 0,1-0,4 mIU/l.